NIH VideoCast - Multiple Myeloma and its Precursor Disease: the Future is Already Here

Skip Navigation

Multiple Myeloma and its Precursor Disease: the Future is Already Here

Loading... Loading video...

428 Views

Air date:	Friday, April 20, 2012, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 428 (56 Live, 372 On-demand)
Category:	NIH Director's Seminars
Runtime:	00:49:40
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director's Seminar Series Dr. Landgren received his M.D. in 1995 from the Karolinska Institute (Stockholm, Sweden). Following clinical training as a hematology/internal medicine specialist physician and receipt of a Ph.D. focusing on diagnostics and prognostics in Hodgkin lymphoma (2002) at Karolinska Institute in Sweden, he worked as an attending physician and conducted clinical research on lymphoproliferative malignancies and related precursors. In 2004, he came to the National Cancer Institute, Genetic Epidemiology Branch, DCEG, where he worked as an Investigator before he joined the Medicial Oncology Branch. Dr. Landgren's major research interests are in the treatment, causation, diagnostics and prognostics, and natural history of multiple myeloma and its precursor condition, monoclonal gammopathy of undetermined significance (MGUS). He also studies related hematologic malignancies and their precursors states (including chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis (MBL); Waldenstrom's macroglobulinemia and IgM MGUS), as well as myeloproliferative neoplasms. His research focuses on treatment-, host-, disease-, and immune-related factors in the pathway from precursor to full-blown malignancy, and their relation to outcome. For more information, visit: http://www.nih.gov/about/director/dirsem.htm

NLM Title:	Multiple myeloma and its precursor disease : the future is already here / Ola Landgren.
Author:	Landgren, Ola. National Institutes of Health (U.S.)
Publisher:
Abstract:	(CIT): NIH Director's Seminar Series Dr. Landgren received his M.D. in 1995 from the Karolinska Institute (Stockholm, Sweden). Following clinical training as a hematology/internal medicine specialist physician and receipt of a Ph.D. focusing on diagnostics and prognostics in Hodgkin lymphoma (2002) at Karolinska Institute in Sweden, he worked as an attending physician and conducted clinical research on lymphoproliferative malignancies and related precursors. In 2004, he came to the National Cancer Institute, Genetic Epidemiology Branch, DCEG, where he worked as an Investigator before he joined the Medicial Oncology Branch. Dr. Landgren's major research interests are in the treatment, causation, diagnostics and prognostics, and natural history of multiple myeloma and its precursor condition, monoclonal gammopathy of undetermined significance (MGUS). He also studies related hematologic malignancies and their precursors states (including chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis (MBL); Waldenstrom's macroglobulinemia and IgM MGUS), as well as myeloproliferative neoplasms. His research focuses on treatment-, host-, disease-, and immune-related factors in the pathway from precursor to full-blown malignancy, and their relation to outcome.
Subjects:	Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma
Publication Types:	Lecture Webcast

NLM Classification:	WH 540
NLM ID:	101585239
CIT Live ID:	10759
Permanent link:	https://videocast.nih.gov/watch=10759

Related Videos...